FDA inspection
Merck Sharp & Dohme: FDA inspection ending Oct 5, 2007
FDA inspection 494216 · Voluntary Action Indicated (VAI) · Summit, NJ
Key facts
| Inspection ID | 494216 |
|---|---|
| Firm | Merck Sharp & Dohme |
| FEI number | 3005906814 |
| Address | 556 Morris Ave |
| City | Summit |
| State | NJ |
| ZIP | 07901-1330 |
| Fiscal year | 2008 |
| Inspection end date | Oct 5, 2007 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Bio-Research Monit: Human Drugs |
| Product type | Drugs |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data